Integra LifeSciences Cuts FY26 Guidance Following Cincinnati Facility Flooding; Stock Tumbles 11.4%
(RTTNews) - Providing certain unaudited preliminary third quarter results on Friday, medical technology company Integra LifeSciences Holdings Corp. (IART) trimmed its adjusted earnings and revenue guidance for the full-year 2026, based on revised assumptions regarding the expecte
Princeton, New Jersey - Integra LifeSciences has reduced its 2026 earnings forecast due to flooding-related disruptions at its Cincinnati manufacturing plant. The company now anticipates third-quarter revenue of $410 million to $412 million and adjusted earnings per share of $0.55 to $0.59 for Q3. For the entire year, Integra has lowered its revenue outlook to $1.634 billion to $1.654 billion and adjusted earnings per share to $2.30 to $2.40.
The flooding damaged portions of the facility, equipment, inventory, and other assets, causing a $7 million revenue shortfall in Q3 and an estimated $15 million to $20 million hit in Q4. Integra expects to resume full operations at the site in the second quarter of 2027. The company has used its inventory and alternative supply sources to mitigate the impact.
Chairman and CEO Stuart Essig expects operating cash flow to exceed $85 million in Q3 and $190 million to $200 million for the year. Full third-quarter 2026 results will be disclosed in a conference call in October 2026.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
